Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Cell Reports
|
December 12, 2019
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz, Daniel Sanghoon Shin, Blanca Homet Moreno, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 23, 2022
<sup>18</sup>F-FDG PET Visualizes Systemic STING Agonist-Induced Lymphocyte Activation in Preclinical Models
Thuc M Le, Hailey R Lee, Evan R Abt, et al.
Cancer Discovery
|
January 29, 2014
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis
Tiffany J Parmenter, Margarete Kleinschmidt, Kathryn M Kinross, et al.
Nature Communications
|
August 2, 2016
Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors
Helena Escuin-Ordinas, Shuoran Li, Michael W Xie, et al.
Biorxiv : the Preprint Server for Biology
|
February 12, 2026
Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 Immunotherapy
Matthew P Zimmerman, Amy C Huang, Emily K Cox, et al.
Cancer Discovery
|
July 1, 2024
Expression of Concern: Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity
Aayoung Hong, Marco Piva, Sixue Liu, et al.
The Journal of Clinical Investigation
|
June 2, 2022
Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunity
Evan R Abt, Khalid Rashid, Thuc M Le, et al.
Cancer Discovery
|
December 15, 2020
Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity
Aayoung Hong, Marco Piva, Sixue Liu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 27, 2015
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
Douglas B Johnson, Alexander M Menzies, Lisa Zimmer, et al.
Nature Medicine
|
April 15, 2020
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy
Eva Pérez-Guijarro, Howard H Yang, Romina E Araya, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Cell Reports
|
December 12, 2019
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz, Daniel Sanghoon Shin, Blanca Homet Moreno, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 23, 2022
<sup>18</sup>F-FDG PET Visualizes Systemic STING Agonist-Induced Lymphocyte Activation in Preclinical Models
Thuc M Le, Hailey R Lee, Evan R Abt, et al.
Cancer Discovery
|
January 29, 2014
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis
Tiffany J Parmenter, Margarete Kleinschmidt, Kathryn M Kinross, et al.
Nature Communications
|
August 2, 2016
Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors
Helena Escuin-Ordinas, Shuoran Li, Michael W Xie, et al.
Biorxiv : the Preprint Server for Biology
|
February 12, 2026
Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 Immunotherapy
Matthew P Zimmerman, Amy C Huang, Emily K Cox, et al.
Cancer Discovery
|
July 1, 2024
Expression of Concern: Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity
Aayoung Hong, Marco Piva, Sixue Liu, et al.
The Journal of Clinical Investigation
|
June 2, 2022
Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunity
Evan R Abt, Khalid Rashid, Thuc M Le, et al.
Cancer Discovery
|
December 15, 2020
Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity
Aayoung Hong, Marco Piva, Sixue Liu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 27, 2015
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
Douglas B Johnson, Alexander M Menzies, Lisa Zimmer, et al.
Nature Medicine
|
April 15, 2020
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy
Eva Pérez-Guijarro, Howard H Yang, Romina E Araya, et al.
Page
of 6